Abvance Therapeutics has appointed Edward Raskin as CEO
Baxter has appointed Andrew Hider as CEO
Incyte CEO Hervé Hoppenot has retired; he is succeeded by Bill Meury
Sun Pharmaceutical has selected Richard Ascroft to lead its North America operations as CEO, replacing Abhay Gandhi
Virtual Incision has appointed Jim Alecxih as CEO
Vor Bio CEO Robert Ang has stepped down; Jean-Paul Kress has replaced him